| Pax genes and organogenesis E Dahl, H Koseki, R Balling Bioessays 19 (9), 755-765, 1997 | 509 | 1997 |
| Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity H Lue, M Thiele, J Franz, E Dahl, S Speckgens, L Leng, ... Oncogene 26 (35), 5046-5059, 2007 | 439 | 2007 |
| CD24 expression is a new prognostic marker in breast cancer G Kristiansen, KJ Winzer, E Mayordomo, J Bellach, K Schlüns, C Denkert, ... Clinical cancer research 9 (13), 4906-4913, 2003 | 425 | 2003 |
| CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival G Kristiansen, C Denkert, K Schlüns, E Dahl, C Pilarsky, S Hauptmann The American journal of pathology 161 (4), 1215, 2002 | 362 | 2002 |
| The diversity of connexin genes encoding gap junctional proteins. K Willecke, H Hennemann, E Dahl, S Jungbluth, R Heynkes European journal of cell biology 56 (1), 1, 1991 | 322 | 1991 |
| Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis J Veeck, D Niederacher, H An, E Klopocki, F Wiesmann, B Betz, O Galm, ... Oncogene 25 (24), 3479-3488, 2006 | 302 | 2006 |
| Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ... BMC cancer 8, 1-15, 2008 | 281 | 2008 |
| Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system B Delorme, E Dahl, T Jarry-Guichard, JP Briand, K Willecke, D Gros, ... Circulation research 81 (3), 423-437, 1997 | 269 | 1997 |
| Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival G Kristiansen, C Pilarsky, C Wissmann, S Kaiser, T Bruemmendorf, ... The Journal of pathology 205 (3), 359-376, 2004 | 236 | 2004 |
| Molecular cloning and functional expression of mouse connexin-30, a gap junction gene highly expressed in adult brain and skin E Dahl, D Manthey, Y Chen, HJ Schwarz, YS Chang, PA Lalley, ... Journal of Biological Chemistry 271 (30), 17903-17910, 1996 | 230 | 1996 |
| Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3 J Veeck, E Dahl Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2011 | 221 | 2011 |
| Molecular cloning and functional expression of mouse connexin40, a second gap junction gene preferentially expressed in lung H Hennemann, T Suchyna, H Lichtenberg-Fraté, S Jungbluth, E Dahl, ... The Journal of cell biology 117 (6), 1299-1310, 1992 | 217 | 1992 |
| Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. E Klopocki, G Kristiansen, PJ Wild, I Klaman, E Castanos-Velez, G Singer, ... International journal of oncology 25 (3), 641, 2004 | 211 | 2004 |
| Mouse connexin37: cloning and functional expression of a gap junction gene highly expressed in lung. K Willecke, R Heynkes, E Dahl, R Stutenkemper, H Hennemann, ... The Journal of cell biology 114 (5), 1049-1057, 1991 | 209 | 1991 |
| Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans HE Wasmuth, F Lammert, MM Zaldivar, R Weiskirchen, C Hellerbrand, ... Gastroenterology 137 (1), 309-319. e3, 2009 | 204 | 2009 |
| The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition E Liepinsh, R Barbals, E Dahl, A Sharipo, E Staub, G Otting Journal of molecular biology 332 (5), 1155-1163, 2003 | 198 | 2003 |
| Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system B Delorme, E Dahl, T Jarry‐guichard, I Marics, JP Briand, K Willecke, ... Developmental Dynamics 204 (4), 358-371, 1995 | 196 | 1995 |
| Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer R Stoehr, C Wissmann, H Suzuki, R Knuechel, RC Krieg, E Klopocki, ... Laboratory investigation 84 (4), 465-478, 2004 | 190 | 2004 |
| Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer E Dahl, G Kristiansen, K Gottlob, I Klaman, E Ebner, B Hinzmann, ... Clinical Cancer Research 12 (13), 3950-3960, 2006 | 189 | 2006 |
| Targeted disruption of Pax1 defines its null phenotype and proves haploinsufficiency B Wilm, E Dahl, H Peters, R Balling, K Imai Proceedings of the National Academy of Sciences 95 (15), 8692-8697, 1998 | 178 | 1998 |
Arndt HartmannProfessor für Pathologie, Universotät Erlangen-NürnbergVerified email at uk-erlangen.de
